Gossamer Bio (GOSS) Prepaid Assets (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Prepaid Assets of $16.1 million for Q1 2026, up 46.64% year-over-year from $11.0 million in Q1 2025, and down 13.07% quarter-over-quarter from $18.5 million in Q4 2025.
Gossamer Bio (GOSS) Prepaid Assets (2018 - 2026) Analysis & Trends
Gossamer Bio's Prepaid Assets history runs 9 years deep, the most recent figure standing at $16.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 46.64% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (up 46.64% YoY), while the FY2025 annual figure was $18.5 million, up 84.26% from the prior year.
- Prepaid Assets for Q1 2026 stood at $16.1 million, down from $18.5 million in the prior quarter.
- The five-year high for Prepaid Assets was $18.5 million in Q4 2025, with the low at $6.2 million in Q4 2022.
- The 5-year median for Prepaid Assets is $10.9 million (2024), against an average of $11.5 million.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets dropped 24.18% in 2022, then soared 84.26% in 2025.
- Gossamer Bio's Prepaid Assets stood at $6.2 million in 2022, then jumped by 62.75% to $10.1 million in 2023, then dropped by 0.61% to $10.0 million in 2024, then jumped by 84.26% to $18.5 million in 2025, then decreased by 13.07% to $16.1 million in 2026.
- Business Quant data shows GOSS's Prepaid Assets at $16.1 million in Q1 2026, $18.5 million in Q4 2025, and $14.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Gossamer Bio | 49.15 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.59 Mn |
| Mar 31, 2026 | 16.07 Mn |
| Dec 31, 2025 | 18.49 Mn |
| Sep 30, 2025 | 14.52 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Mar 31, 2025 | 10.96 Mn |
| Dec 31, 2024 | 10.03 Mn |
| Sep 30, 2024 | 10.65 Mn |
| Jun 30, 2024 | 12.79 Mn |
| Mar 31, 2024 | 10.88 Mn |
| Dec 31, 2023 | 10.09 Mn |
| Sep 30, 2023 | 12.60 Mn |
| Jun 30, 2023 | 11.25 Mn |
| Mar 31, 2023 | 8.56 Mn |
| Dec 31, 2022 | 6.20 Mn |
| Sep 30, 2022 | 7.65 Mn |
| Jun 30, 2022 | 10.52 Mn |
| Mar 31, 2022 | 9.09 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Sep 30, 2021 | 7.91 Mn |